Acromegaly is treated through a combination of surgery, medication, and sometimes radiation, with the goal of bringing growth hormone and IGF-1 levels back to normal. Surgery is the first-line treatment for most people, and medications can control the disease when surgery doesn’t fully succeed. The specific approach depends on the size and location of the tumor, how elevated your hormone levels are, and whether the condition has already caused complications like diabetes or heart problems.
Surgery Is the First Step for Most People
The primary treatment for acromegaly is surgery to remove the pituitary tumor causing the excess growth hormone. The procedure is called transsphenoidal surgery because surgeons reach the pituitary gland through the nose and sinuses, avoiding the need to open the skull. It’s performed by a neurosurgeon, typically one who specializes in pituitary tumors.
Success rates depend heavily on tumor size. For smaller tumors (microadenomas), endoscopic surgery achieves remission in roughly 87% of cases. For larger tumors (macroadenomas), that number drops to about 72%. Older data using microscopic rather than endoscopic techniques showed even wider variation: 67% to 95% remission for small tumors and 47% to 68% for large ones. The shift toward endoscopic approaches has generally improved outcomes for larger tumors.
Recovery from the surgery itself is relatively quick, usually a few days in the hospital followed by several weeks of healing. But “remission” in acromegaly is measured by blood tests, not just how you feel. Your doctors will check whether your IGF-1 levels have returned to the normal range for your age. If they have, no further treatment may be needed. If levels remain elevated, medication is the next step.
Medications That Lower Growth Hormone
When surgery doesn’t fully normalize hormone levels, or when a tumor can’t be safely removed, medications become the main treatment. There are three classes of drugs used, each working through a different mechanism.
Somatostatin Analogs
These are the most commonly prescribed medications for acromegaly. They mimic a natural brain hormone called somatostatin, which tells the pituitary gland to reduce growth hormone output. The two main options are octreotide and lanreotide, both given as injections.
Lanreotide, for example, starts at a dose injected deep under the skin every four weeks. After three months, your doctor adjusts the dose based on your hormone levels and symptoms. If your levels are well controlled, the injection interval can sometimes be stretched to every six or eight weeks, which means fewer trips for treatment. These drugs control hormone levels in roughly half to two-thirds of patients and can also shrink the tumor in some cases.
The most common side effects are digestive: nausea, diarrhea, abdominal discomfort, and an increased risk of gallstones over time. Most people tolerate them well enough to stay on treatment long-term.
Growth Hormone Receptor Blockers
Pegvisomant works differently from somatostatin analogs. Rather than reducing how much growth hormone the pituitary releases, it blocks growth hormone from acting on tissues throughout the body. This makes it exceptionally effective at normalizing IGF-1 levels. In a long-term study, 97% of patients treated for 12 months or more achieved normal IGF-1 concentrations.
Pegvisomant is given as a daily injection. Because it doesn’t shrink the tumor or lower growth hormone production, patients on this drug need periodic imaging to monitor tumor size. In rare cases, tumor growth has been observed. Liver enzyme elevations can also occur, so blood tests to monitor liver function are part of routine follow-up.
This medication is typically reserved for people who don’t respond adequately to somatostatin analogs, or it’s used in combination with them.
Dopamine Agonists
Cabergoline is an oral medication originally developed for a different type of pituitary tumor but sometimes useful in acromegaly. Guidelines recommend it for people with only mildly elevated IGF-1 after surgery, or as an add-on when somatostatin analogs alone aren’t enough. Typical doses range from 0.5 mg to 1 mg taken twice weekly.
As a standalone treatment, cabergoline is only moderately effective. Its real value is in combination therapy. In one trial, adding cabergoline to pegvisomant brought IGF-1 into the normal range for 68% of patients who hadn’t responded to single-drug treatment. The appeal of cabergoline is that it’s a pill rather than an injection, which can simplify a treatment regimen that already involves regular shots.
Radiation When Surgery and Medication Fall Short
Radiation therapy is considered when surgery hasn’t removed enough of the tumor and medications aren’t controlling hormone levels adequately. It works by damaging the tumor cells so they gradually stop producing excess growth hormone, but the key word is “gradually.”
With conventional fractionated radiotherapy, delivered in many small doses over several weeks, remission typically takes about 10 years. That long delay is one reason radiation has traditionally been a last resort. Newer, more focused techniques have shortened the timeline considerably. Stereotactic radiosurgery, which delivers a single high-dose beam precisely targeted to the tumor, typically achieves remission within three years. A newer robotic approach has shown even faster results in small studies, with an average time to remission of about one year, though the evidence base for that is still limited.
During the years it takes for radiation to work, you’ll still need medication to control your hormone levels. The most significant long-term risk of radiation is damage to the surrounding healthy pituitary tissue, which can lead to deficiencies in other hormones like thyroid hormone, cortisol, or sex hormones. Most people who undergo pituitary radiation eventually need hormone replacement therapy for one or more of these.
Managing the Health Problems Acromegaly Causes
Treating the tumor and normalizing growth hormone is only part of the picture. Years of elevated growth hormone and IGF-1 affect how your body handles sugar and fat, put strain on the heart, and change bone and joint structure. Even after hormone levels return to normal, some of these effects persist and need their own management.
The most common complications include type 2 diabetes, high blood pressure, heart disease (including enlargement of the heart muscle), arthritis, sleep apnea, and colon polyps that carry an increased risk of colon cancer. After diagnosis, your care team will typically order an echocardiogram to evaluate your heart, a sleep study to check for sleep apnea, a colonoscopy to screen for polyps, and bone density testing.
Some of these problems improve or resolve once growth hormone is controlled. Blood sugar and blood pressure often get better, though they may not fully normalize. Joint damage and bone changes, on the other hand, tend to be permanent. Sleep apnea frequently improves but may require ongoing treatment with a CPAP machine. Colonoscopies are generally recommended at regular intervals even after hormone levels normalize, because the elevated polyp risk can persist.
What Treatment Success Looks Like
The goal of treatment is to bring IGF-1 into the normal range for your age and to get random growth hormone levels as low as possible. When IGF-1 is more than 1.3 times above the upper limit of normal for your age, the disease is considered active. Getting below that threshold, ideally into the fully normal range, is what doctors aim for.
In practice, treatment is a long-term process. Many people go through surgery first, then spend months adjusting medications, with blood tests every few months to track hormone levels. Some people achieve remission with surgery alone and need nothing further. Others require lifelong medication, dose adjustments, or combination therapy to stay controlled. The physical changes that have already occurred, like enlarged hands, feet, and facial features, don’t reverse after treatment, but soft tissue swelling often decreases and symptoms like headaches, joint pain, and excessive sweating typically improve.
Because acromegaly develops slowly and has wide-reaching effects, treatment usually involves an endocrinologist coordinating with a neurosurgeon, a radiation oncologist if needed, and specialists managing individual complications like a cardiologist or sleep medicine doctor. Regular follow-up continues for years, even after remission, to catch any recurrence early.